Seminars in Radiation Oncology
Volume 18, Issue 4 , Pages 257-264, October 2008

Clinical Experience Using Hypofractionated Radiation Schedules in Breast Cancer

  • Timothy J. Whelan, BM, BCh, MSc

      Affiliations

    • Department of Oncology, McMaster University, Hamilton, Ontario, Canada
    • Juravinski Cancer Centre, Hamilton, Ontario, Canada
    • Corresponding Author InformationAddress reprint requests to Timothy J. Whelan, BM, BCh, MSc, Juravinski Cancer Centre, 699 Concession Street, Rm 4-204, Hamilton, Ontario, Canada, L8V 5C2
  • ,
  • Do-Hoon Kim, MD

      Affiliations

    • Juravinski Cancer Centre, Hamilton, Ontario, Canada
  • ,
  • Jonathan Sussman, MD, CCFP, FRCP(C), MSc

      Affiliations

    • Department of Oncology, McMaster University, Hamilton, Ontario, Canada
    • Juravinski Cancer Centre, Hamilton, Ontario, Canada

Hypofractionation is attractive for whole- or partial-breast irradiation because it permits treatment to be given with fewer fractions in a shorter period of time and at less cost. A number of cohort studies suggest that hypofractionation may be given to the whole breast safely and with good local control. Recent randomized trials have confirmed that hypofractioned whole-breast irradiation is equivalent to more conventional whole-breast irradiation with respect to local recurrence and cosmetic outcome. Recently, there has been a renewed interest in hypofractionation for the delivery of partial-breast irradiation using a number of techniques including high-dose rate brachytherapy, 3-dimensional conformal radiation using external-beam techniques, and intraoperative therapy. Early cohort studies report good local control and acceptable morbidity. Randomized trials are now underway to compare this approach to conventional whole-breast irradiation.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Whelan is supported by a Canada Research Chair in Breast Cancer.

PII: S1053-4296(08)00037-4

doi:10.1016/j.semradonc.2008.04.008

Seminars in Radiation Oncology
Volume 18, Issue 4 , Pages 257-264, October 2008